247 related articles for article (PubMed ID: 33563867)
1. Pulmonary Hypertension Associated With Respiratory Diseases - Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
Sakamaki F; Asano K
Circ J; 2021 Mar; 85(4):343-344. PubMed ID: 33563867
[No Abstract] [Full Text] [Related]
2. Update on pediatric pulmonary arterial hypertension.
Ivy D; Frank BS
Curr Opin Cardiol; 2021 Jan; 36(1):67-79. PubMed ID: 33136663
[TBL] [Abstract][Full Text] [Related]
3. Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
Bogaard HJ; Sitbon O
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33509909
[No Abstract] [Full Text] [Related]
4. Surrogate endpoints in pulmonary arterial hypertension trials.
Hoeper MM
Lancet Respir Med; 2023 Oct; 11(10):852-853. PubMed ID: 37230096
[No Abstract] [Full Text] [Related]
5. Continued Progress in Therapy for Pulmonary Arterial Hypertension.
Taichman DB; Leopold JA; Elliott G
N Engl J Med; 2023 Apr; 388(16):1524-1526. PubMed ID: 36876747
[No Abstract] [Full Text] [Related]
6. Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension.
Humbert M
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37918877
[No Abstract] [Full Text] [Related]
7. Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
Jin Q; Guan L; Pan W; Zhou D
Am J Respir Crit Care Med; 2021 Dec; 204(12):1491-1492. PubMed ID: 34672865
[No Abstract] [Full Text] [Related]
8. Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
Weatherald J; Moutchia J; Al-Naamani N; McClelland RL; Ventetuolo CE; Palevsky HI; Harhay MO; Kawut SM
Am J Respir Crit Care Med; 2023 Dec; 208(11):1231-1234. PubMed ID: 37734029
[No Abstract] [Full Text] [Related]
9. Upfront Combination Therapy: Growing the Case to Get Ahead of Pediatric Pulmonary Arterial Hypertension.
Steffes LC; Austin ED
Ann Am Thorac Soc; 2022 Feb; 19(2):163-165. PubMed ID: 35103566
[No Abstract] [Full Text] [Related]
10. The Pathobiology of Pulmonary Arterial Hypertension.
Rajagopal S; Yu YA
Cardiol Clin; 2022 Feb; 40(1):1-12. PubMed ID: 34809910
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin I
Norlander AE; Abney M; Cephus JY; Roe CE; Irish JM; Shelburne NJ; Newcomb DC; Hemnes AR; Peebles RS
Am J Respir Crit Care Med; 2023 Sep; 208(6):737-739. PubMed ID: 37413696
[No Abstract] [Full Text] [Related]
12. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
Aman J; Hovingh GK
Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
[No Abstract] [Full Text] [Related]
13. Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.
Deng J
J Cardiothorac Surg; 2021 Oct; 16(1):311. PubMed ID: 34670595
[TBL] [Abstract][Full Text] [Related]
14. Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No.
Sahay S
Chest; 2024 Mar; 165(3):494-496. PubMed ID: 38461012
[No Abstract] [Full Text] [Related]
15. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
Austin ED; Hamid R
Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
[No Abstract] [Full Text] [Related]
16. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
[No Abstract] [Full Text] [Related]
17. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
Maron BA; Humbert M
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
[No Abstract] [Full Text] [Related]
18. POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
Weatherald J; Sitbon O
Chest; 2024 Mar; 165(3):492-494. PubMed ID: 38461011
[No Abstract] [Full Text] [Related]
19. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
[No Abstract] [Full Text] [Related]
20. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
Grinnan D; Farkas L
Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
